Allogeneic bone marrow transplantation for children with acute leukemia: Cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide

Bone Marrow Transplantation

Volumn 25, Issue 5, 2000, Pages 489-494

  Duerst, R E ^a   Horan, J T ^a   Liesveld, J L ^a   Abboud, C N ^a   Zwetsch, L M ^a   Senf, E S ^a   Constine, L S ^b   Raubertas, R F ^c   Passarell, J A ^c   DiPersio, J F ^a,d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Allogeneic marrow transplantation; Children; Cyclophosphamide; Etoposide; Total body irradiation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; GANCICLOVIR; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOXICITY; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 17644439186     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702181     Document Type: Article

References (23)

1. Sanders JE, Thomas ED, Buckner CD et al. Marrow transplantation tor children in first remission of acute non-lymphoblastic leukemia: an update. Blood 1985; 66: 460-462.
2. Brochstein JA, Kernan NA, Goshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body-irradiation and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
3. Clift RA, Buckner CD, Applebaum FR et al. Allogeneic bone marrow transplantation in patients with AML in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867-1871.
4. Lynch MHE, Petersen FB, Applebaum FR et al. Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies. Bone Marrow Transplant 1996; 15: 59-64.
5. Hongeng S, Krance RA, Bowman LC et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukemia. Lancet 1997; 350: 767-771.
6. Brown RA, Wolff SN, Fay JW et al. High-dose etoposide, cyclophosphamide, and total-body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first relapse: a study by the North American Marrow Transplant Group. Blood 1995; 85: 1391-1395.
7. Giralt SA, LeMaistre CF, Vriesendorp HM et al. Etoposide, cyclophosphamide, total-body irradiation and allogeneic bone marrow transplantation for hematologic malignancies. J Clin Oncol 1994; 12: 1923-1930.
8. Yau JC, LeMaistre CF, Andersson BS et al. Allogeneic bone marrow transplantation for hematologic malignancies following etoposide, cyclophosphamide and total-body irradiation. Am J Hematol 1992; 41: 40-44.
9. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974; 18: 295-299.
10. Seber A, Vogelsang GB. Chronic graft-versus-host disease. In: Barrett J, Treleaven J (eds). The Clinical Practice of Stem-Cell Transplantation. Mosby-Year Book Inc: St Louis, MO, 1998, p 621.
11. Bearman SI, Applebaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
12. Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15: 1767-1777.
13. Blume KG, Kopecky KJ, Henslee-Downey JP et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamicle as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: A Southwest Oncology Group Study. Blood 1993; 81: 2187-2193.
14. Amylon MD, Co JP, Snyder DS et al. Allogeneic bone marrow transplant in pediatric patients with high risk hematopoietic malignancies early in the course of their disease. J Pediatr Hematol Oncol 1997; 19: 54-61.
15. Chang T, Gulati S, Chou T et al. Synergistic effect of 4-hydroxycylophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis. Cancer Res 1985; 45: 2234-2339.
16. Parsons SK, Castellino SM, Lehmann LE et al. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Bone Marrow Transplant 1996; 17: 763-768.
17. Horstmann M, Kroschke G, Stockschlader M et al. Early toxicily of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/ cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation. Pediatr Hematol Oncol 1996; 13: 45-53.
18. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
19. Weiner RS, Bortin MM, Gale RP et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986; 104: 168-175.
20. Weiner RS, Horowitz MM, Gale RP et al. Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anemia. Br J Haematol 1989; 71: 535-543.
21. Rozman C, Carreras E, Qian C et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 1996; 17: 75-80.
22. Horowitz MM, Bortin MM. Results of bone marrow transplants from human leukocyte antigen identical sibling donors for treatment of childhood leukemias: a report from the international bone marrow transplant registry. Am J Pediatr Hematol/Oncol 1993; 15: 56-64.
23. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.